F2

The 3X4 Genetics Test + Blueprint Report provides 36 key insights and practical, personalized recommendations for patients to start taking control of their health.

MedCheck gives insights into a patient's responsiveness to different medications and the likelihood of side effects and treatment failure. It provides insight into how a patient metabolizes, transports, and binds specific drugs, allowing physicians to prescribe medications that are most likely to prove effective with minimal side effects.

This test detects variations in the prothrombin G20210A gene. It identifies individuals with defects in clotting factors. This identification allows physicians to determine the need for more aggressive thrombosis prevention measures for these individuals. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.

This test detects variations in the prothrombin G20210A gene. It identifies individuals with defects in clotting factors. This identification allows physicians to determine the need for more aggressive thrombosis prevention measures for these individuals. This test can be added to any other Boston Heart genetics test. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.

This test detects variations in the prothrombin G20210A gene. It identifies individuals with defects in clotting factors. This identification allows physicians to determine the need for more aggressive thrombosis prevention measures for these individuals. This test can be added to any other Boston Heart genetics test. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.